NASDAQ$MNKD
MannKind Corp · Q4 2019 earnings
Q4 2019 earnings · · Investor relations
Briefing
MannKind reported Q4 2019 earnings, showing revenue growth driven by Afrezza sales and progress in collaborations.
MannKind Corporation's Q4 2019 total revenues reached $16.0 million, with Afrezza net revenue at $7.8 million, a 35% increase compared to Q4 2018. The company's net loss for the quarter was $14.3 million, or $0.07 per share. The collaboration with United Therapeutics on TreT continues to make progress.
- Total revenue for Q4 2019 was $16.0 million.
- Afrezza net revenue for Q4 2019 increased by 35% to $7.8 million compared to Q4 2018.
- Collaborations and services revenue for Q4 2019 decreased by 20% to $8.2 million compared to Q4 2018.
- Net loss for Q4 2019 was $14.3 million, or $0.07 per share.
Headline financials
Revenue & EPS history
MannKind · Revenue · Quarterly
$16M
Revenue by segment
MannKind · $16M total across 2 segments · Q4 2019
- Collaborations and services$8.23M-20.5%51.5%
- Afrezza$7.76M+35.4%48.5%
Forward guidance
MannKind is working with United Therapeutics on TreT and expects to file with the FDA within 12 months.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2019
-0.4%
Avg return
Earnings day
-0.7%
Avg return
5 days after
+1.5%
Avg return
30 days after
39%
25 / 64 earnings
Positive
+44.9%
Q3 2016
Best reaction
-28.5%
Q1 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +24.5% | +17.5% | +18.5% | |
| Q4 2025 | -6.9% | -16.3% | -34.9% | |
| Q3 2025 | +10.6% | -1.1% | +3.6% | |
| Q1 2025 | -4.5% | -2.7% | -9.7% | |
| Q4 2024 | -4.4% | -5.9% | -8.0% | |
| Q3 2024 | -1.2% | -4.8% | -8.6% | |
| Q2 2024 | -1.5% | -1.5% | +12.5% | |
| Q1 2024 | -3.6% | -1.3% | +4.5% | |
| Q4 2023 | +9.5% | +25.7% | +26.5% | |
| Q3 2023 | -0.8% | -6.8% | -0.3% | |
| Q2 2023 | +15.5% | +11.2% | -3.8% | |
| Q1 2023 | +13.4% | +9.0% | +6.2% | |
| Q4 2022 | +4.2% | +1.7% | -23.1% | |
| Q3 2022 | +6.3% | +20.7% | +32.8% | |
| Q2 2022 | -1.4% | -4.6% | -9.0% | |
| Q1 2022 | -8.7% | -8.7% | +42.7% | |
| Q4 2021 | -25.7% | -24.9% | -5.2% | |
| Q3 2021 | -0.6% | +3.1% | -14.3% | |
| Q2 2021 | +5.1% | +5.4% | +20.8% | |
| Q1 2021 | -8.4% | -3.9% | -8.0% | |
| Q4 2020 | -4.5% | -36.8% | -40.0% | |
| Q3 2020 | +8.8% | +19.0% | +43.9% | |
| Q2 2020 | +0.0% | -4.2% | -1.2% | |
| Q1 2020 | -2.2% | -0.7% | +4.5% | |
| Q4 2019 | -7.9% | -16.4% | -27.6% | |
| Q3 2019 | -15.1% | -16.8% | -18.8% | |
| Q2 2019 | -0.9% | +4.6% | +13.9% | |
| Q1 2019 | -12.3% | -19.4% | -25.2% | |
| Q4 2018 | +23.8% | +17.2% | +27.8% | |
| Q3 2018 | +0.0% | -1.1% | -2.7% | |
| Q2 2018 | -26.8% | -29.3% | -29.9% | |
| Q1 2018 | +2.3% | +8.7% | +13.3% | |
| Q4 2017 | -10.4% | -13.5% | -30.3% | |
| Q3 2017 | -7.1% | +0.3% | -4.3% | |
| Q2 2017 | -5.7% | -2.5% | +61.5% | |
| Q1 2017 | +13.8% | -5.4% | +39.3% | |
| Q4 2016 | +9.9% | +2.5% | -34.2% | |
| Q3 2016 | +44.9% | +51.2% | +51.2% | |
| Q2 2016 | -6.2% | +2.0% | -27.6% | |
| Q1 2016 | -28.5% | — | — | |
| Q4 2015 | +6.0% | — | — | |
| Q3 2015 | -19.9% | — | — | |
| Q2 2015 | +4.5% | — | — | |
| Q1 2015 | -8.4% | — | — | |
| Q4 2014 | +2.8% | — | — | |
| Q3 2014 | -1.5% | — | — | |
| Q2 2014 | -8.0% | — | — | |
| Q1 2014 | +5.8% | — | — | |
| Q4 2013 | +5.9% | — | — | |
| Q3 2013 | +7.3% | — | — | |
| Q2 2013 | -5.1% | — | — | |
| Q1 2013 | +11.0% | — | — | |
| Q4 2012 | -1.9% | — | — | |
| Q3 2012 | +2.6% | — | — | |
| Q2 2012 | +3.9% | — | — | |
| Q1 2012 | -8.3% | — | — | |
| Q4 2011 | +7.9% | — | — | |
| Q3 2011 | -1.6% | — | — | |
| Q2 2011 | -10.1% | — | — | |
| Q1 2011 | -11.8% | — | — | |
| Q4 2010 | -5.5% | — | — | |
| Q3 2010 | -2.3% | — | — | |
| Q2 2010 | -0.7% | — | — | |
| Q1 2010 | +3.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro